241 related articles for article (PubMed ID: 10984532)
1. Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin.
Shriver Z; Sundaram M; Venkataraman G; Fareed J; Linhardt R; Biemann K; Sasisekharan R
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10365-70. PubMed ID: 10984532
[TBL] [Abstract][Full Text] [Related]
2. Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site.
Yu G; LeBrun L; Gunay NS; Hoppensteadt D; Walenga JM; Fareed J; Linhardt RJ
Thromb Res; 2000 Dec; 100(6):549-56. PubMed ID: 11152935
[TBL] [Abstract][Full Text] [Related]
3. Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site.
Shriver Z; Raman R; Venkataraman G; Drummond K; Turnbull J; Toida T; Linhardt R; Biemann K; Sasisekharan R
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10359-64. PubMed ID: 10984531
[TBL] [Abstract][Full Text] [Related]
4. Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.
Ernst S; Rhomberg AJ; Biemann K; Sasisekharan R
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4182-7. PubMed ID: 9539710
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of antithrombin III binding site in low molecular weight heparins by exhausetive heparinases digestion and capillary electrophoresis.
Zhang M; Li G; Zhang Y; Kang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():78-83. PubMed ID: 29031112
[TBL] [Abstract][Full Text] [Related]
6. Structural studies on the bacterial lyase-resistant tetrasaccharides derived from the antithrombin III-binding site of porcine intestinal heparin.
Yamada S; Yoshida K; Sugiura M; Sugahara K; Khoo KH; Morris HR; Dell A
J Biol Chem; 1993 Mar; 268(7):4780-7. PubMed ID: 8444855
[TBL] [Abstract][Full Text] [Related]
7. Search for the heparin antithrombin III-binding site precursor.
Linhardt RJ; Wang HM; Loganathan D; Bae JH
J Biol Chem; 1992 Feb; 267(4):2380-7. PubMed ID: 1733939
[TBL] [Abstract][Full Text] [Related]
8. Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages.
Xiao Z; Zhao W; Yang B; Zhang Z; Guan H; Linhardt RJ
Glycobiology; 2011 Jan; 21(1):13-22. PubMed ID: 20729345
[TBL] [Abstract][Full Text] [Related]
9. Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase. Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site.
Tsuda H; Yamada S; Yamane Y; Yoshida K; Hopwood JJ; Sugahara K
J Biol Chem; 1996 May; 271(18):10495-502. PubMed ID: 8631846
[TBL] [Abstract][Full Text] [Related]
10. Heparinase II from Flavobacterium heparinum. Role of histidine residues in enzymatic activity as probed by chemical modification and site-directed mutagenesis.
Shriver Z; Hu Y; Sasisekharan R
J Biol Chem; 1998 Apr; 273(17):10160-7. PubMed ID: 9553064
[TBL] [Abstract][Full Text] [Related]
11. Synthetic heparin pentasaccharide depolymerization by heparinase I: molecular and biological implications.
Daud AN; Ahsan A; Iqbal O; Walenga JM; Silver PJ; Ahmad S; Fareed J
Clin Appl Thromb Hemost; 2001 Jan; 7(1):58-64. PubMed ID: 11190907
[TBL] [Abstract][Full Text] [Related]
12. Uncovering the detailed mode of cleavage of heparinase I toward structurally defined heparin oligosaccharides.
Zhang C; Tang F; Zhang J; Cao J; Li H; Liu C
Int J Biol Macromol; 2019 Dec; 141():756-764. PubMed ID: 31479666
[TBL] [Abstract][Full Text] [Related]
13. Controllable production of low molecular weight heparins by combinations of heparinase I/II/III.
Wu J; Zhang C; Mei X; Li Y; Xing XH
Carbohydr Polym; 2014 Jan; 101():484-92. PubMed ID: 24299802
[TBL] [Abstract][Full Text] [Related]
14. A comparative analysis of the primary sequences and characteristics of heparinases I, II, and III from Flavobacterium heparinum.
Godavarti R; Sasisekharan R
Biochem Biophys Res Commun; 1996 Dec; 229(3):770-7. PubMed ID: 8954971
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificity of the heparin lyases from Flavobacterium heparinum.
Desai UR; Wang HM; Linhardt RJ
Arch Biochem Biophys; 1993 Nov; 306(2):461-8. PubMed ID: 8215450
[TBL] [Abstract][Full Text] [Related]
16. Production, characteristics and applications of microbial heparinases.
Boyce A; Walsh G
Biochimie; 2022 Jul; 198():109-140. PubMed ID: 35367577
[TBL] [Abstract][Full Text] [Related]
17. Profiling glycol-split heparins by high-performance liquid chromatography/mass spectrometry analysis of their heparinase-generated oligosaccharides.
Alekseeva A; Casu B; Torri G; Pierro S; Naggi A
Anal Biochem; 2013 Mar; 434(1):112-22. PubMed ID: 23201389
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometric evidence for the enzymatic mechanism of the depolymerization of heparin-like glycosaminoglycans by heparinase II.
Rhomberg AJ; Shriver Z; Biemann K; Sasisekharan R
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12232-7. PubMed ID: 9770469
[TBL] [Abstract][Full Text] [Related]
19. Examination of the substrate specificity of heparin and heparan sulfate lyases.
Linhardt RJ; Turnbull JE; Wang HM; Loganathan D; Gallagher JT
Biochemistry; 1990 Mar; 29(10):2611-7. PubMed ID: 2334685
[TBL] [Abstract][Full Text] [Related]
20. Distinct substrate specificities of bacterial heparinases against N-unsubstituted glucosamine residues in heparan sulfate.
Wei Z; Lyon M; Gallagher JT
J Biol Chem; 2005 Apr; 280(16):15742-8. PubMed ID: 15705564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
